Neonatal screening of hearing function by otoacustic emissions: A single center experience (original) (raw)
Related papers
Success rate of newborn and follow-up screening of hearing using otoacoustic emissions
International journal of pediatric otorhinolaryngology, 2006
During the last 6 years, and after a long period of pilot study, a universal newborn hearing screening program based on otoacoustic emissions is implemented in Iaso Maternity Hospital. Our purpose is to present the success rate of otoacoustic emission testing on discharge from the hospital and 1 month later. All full-term newborns who were screened during a period of 2 years and failed testing after one or more sessions of transiently evoked otoacoustic emissions, on discharge from the hospital, were included in the study. These newborns were retested approximately 1 month after discharge. Twenty-five thousand and thirty-two newborns were examined in total. We found 534 (2.1%) 'refer' cases. Only 223 of them (41.8%) returned to retest in follow-up after 1 month. From the rescreening, 59 (2.3 per thousand) newborns failed in the test again and were referred for diagnostic audiological evaluation. The rate of referrals was small, but efforts should be made to decrease it furth...
Early Detection of Hearing Impairment in Neonates - Screening by Otoacoustic Emission Test
2021
BACKGROUND Approximately 3 per 1000 live births suffer from congenital hearing loss in India. If detected before the age of 6 months, their mental, social and intellectual growth can be restored by early intervention and rehabilitation. Their speech development and social integration depends highly on early detection of hearing loss, at least before the first birthday. We wanted to screen all new-borns for hearing and assess the incidence of hearing impairment in at risk and no risk cases by using otoacoustic emissions. We also wanted to evaluate the two-stage testing by OAE in screening programme. METHODS The present study was conducted from Feb. 1st 2013 to Jan. 31st 2015. A total of 849 infants have been studied of which 63 had high risk factors. RESULTS The overall incidence of hearing impairment was found to be 3.75 / 1000 births in no-risk group whereas 61.22 / 1000 were found in high risk group. CONCLUSIONS Early detection of hearing loss in infants by otoacoustic emission (O...
Oto acoustic emissions in early detection of sensorineural hearing loss in high-risk neonates
International Journal of Otorhinolaryngology and Head and Neck Surgery
Background: Early identification of congenital hearing loss and early intervention ameliorated many adverse consequences. This study was performed to observe effectiveness of otoacoustic emission in screening of hearing loss in high-risk babies.Methods: Prospective study on 45 high-risk newborns delivered during period of 2013-2014. Selective newborn hearing performed with oto acoustic emissions (OAE) and auditory brain stem responses (ABR), in high-risk infants aged below 7 days, 15 days, after 45 days and after 90 days.Results: Study population comprised of 45 high-risk newborns. In 1st level screening, 28 (62%) babies showed recordable OAE, 17 (38%) babies failed. In 2nd level screening 31 (81%) passed and 7 (19%) failed and death occurred in 7 infants. In 3rd level screening both OAE and brain stem evoked response audiometry (BERA), was performed in 38 cases and positivity was reported in 37 cases. 4th level screening was similar to 3rd level screening where 3 babies failed ABR t...
Evaluation of hearing in neonates and infants
Indian Journal of Otolaryngology and Head & Neck Surgery, 1994
Hearinge valuation of sixtyfour neonates and infants selected randomly from the outpatient departments of E. N. T., Paediatrics and Obstetrics wards was done by behavioral observation audiometry (BOA), tympanometry, acoustic reflex and auditory brainstem evoked response audiometry (ABR) in selected cases. A good correlation was found between BOA and ABR. Tympanometry and acoustic reflex measurements were not found to be useful for evaluating hearing status in infants and neonates. It was finally recommended that BOA should be used for screening hearing in infants and neonates. Cases who fail in BOA should be subjected to ABR for establishing true threshold of hearing.
Effectiveness Of Transient Evoked Otoacoustic Emission (TEOAE) Test For Neonatal Auditory Screening
Journal of Bahria University Medical and Dental College, 2018
Objective: The purpose of this study is to assess the efficacy of Transient Evoked Otoacoustic Emission (TEOAE) as screening test for auditory function in neonates. Study Design: A cross-sectional study Place and Duration of Study: This study was conducted at United Medical and Dental College, Creek General Hospital, Karachi, from July 2106 to May 2017. A total number of 120 newborn babies were screened for hearing loss before discharge from hospital but 20 were lost for follow up and 100 cases were included in this study. Method: TEOAE was done in all neonates born during this period at 3rd day after birth. Those who were found to have hearing loss, TEOAE was repeated at the end of 1st week and again in 6th week after birth. BERA was done in those cases who showed hearing loss on TEOAE on all three occasions. All the 100 cases were followed up regularly for more than one year for appearance of any sign or symptom related with hearing loss or speech development failure. Result: Out ...
International Journal of Pediatric Otorhinolaryngology, 2011
Objective: To determine the validity of dichotic multiple frequencies auditory steady-state responses (ASSR) as a hearing screening technique versus using distortion product otoacoustic emissions (DPOAEs) among high-risk neonates. Methods: A cross sectional study was performed on 118 high-risk neonates by means of dichotic multiple frequencies ASSR and DPOAE for hearing screening. DPOAE results were used as the standard for hearing screening in parallel with ASSR. Dichotic multiple frequencies ASSR results were analyzed by means of F-value of less or greater than 0.05 criteria as a pass-fail for the responses. Dichotic multiple ASSR hearing screening technique was considered in two intensity levels at 40 and 70 dB HL. The ASSRs thresholds were measured in high risk neonates with and without hearing deficits as determined by DPOAES. The results of ASSR and DPOAE were compared to be gathered by contingency table in order to obtain sensitivity, specificity and other different statistical values. Average performing times for the tests were analyzed. Results: The specificity of dichotic multiple ASSR was 92.6%, 93.8% and the sensitivity was 71.6%, 62.2% at the 70 and 40 dB hearing levels, respectively. Mean ASSR thresholds for normal-hearing infants at an average corrected age of 6 days were 32.2 AE 12.2, 29.8 AE 10.2, 26.2 AE 11.4 and 30.4 AE 10.8 dB HL for 0.5, 1, 2 and 4 kHz, respectively. The average times for performing the tests were 18.7 and 32.9 min respectively. Conclusions: ASSR with this special paradigm is a fairly desirable method for hearing screening of highrisk neonates. There is good concordance between ASSRs and DOPAEs results among high risk neonates referred for hearing screening. The sensitivity and specificity of this test is sufficient for hearing screening in high risk neonates. This test could be valuable for rapid confirmation of normal thresholds. As long as further research have not been conducted on ASSR, great caution should be made to interpret the results of ASSR as a hearing screening technique in young infants and also additional techniques such as the tone-evoked ABRs should be used to cross-check results. It's still too soon to recommend ASSRs as a standalone electrophysiologic measure of hearing thresholds in infants.
Distortion-product otoacoustic emissions hearing screening in high-risk newborns
Otolaryngology - Head and Neck Surgery, 1998
Universal infant hearing screening has recently been recommended by the National Institutes of Health. Otoacoustic emissions have been proposed as the first-level screening technique. Although transient evoked otoacoustic emissions have shown limited applications, distortion-product otoacoustic emissions hold promise as a screening technique but have not been fully investigated. The purpose of this study was to determine the validity of distortion-product otoacoustic emissions as a hearing screening technique. A total of 208 ears of 104 infants at risk for hearing loss were tested with both automated auditory brain stem response and distortion-product otoacoustic emission screening protocols. Acoustic brain stem response results were used as the standard for normal hearing. Distortion-product otoacoustic emission results were analyzed by means of calculation of the difference between the mean of the response levels and the mean of the noise floor levels from five frequency pairs between 2000 and 4000 Hz. Pass-fail rates for response above noise floor criteria of 5, 10, and 15 dB were examined. The sensitivity of distortion-product otoacoustic emissions was 50%, 67%, and 87%, and the specificity was 94%, 68%, and 38% at the 5, 10, and 15 dB levels, respectively. The pass-fail criterion of distortion-product otoacoustic emissions should be based on instrumentation calibration, infant status, and an acceptable false-positive, false-negative yield. The ability to test rapidly the hearing of all infants with distortion-product otoacoustic emissions points to the feasibility of using this test as a first-stage screen.
The Journal of Laryngology & Otology, 2005
The objective of this prospective study was to report on the prevalence of hearing impairment in the neonatal unit population. From 15 February 2000 to 15 March 2000 and from 15 February 2001 to 15 May 2001, 401 neonates were screened using transient evoked otoacoustic emissions (TEOAE) followed by second-stage screening of those infants who failed the initial test. Eight (2 per cent) infants failed one ear and 23 (5.74 per cent) infants failed both ears, adding up to 7.74 per cent planned for second-stage screening. Five out of 22 infants who came for the follow up failed the screening, resulting in a prevalence of hearing impairment of 1 per cent (95 per cent confidence interval [95% CI]: 0.0–2.0). Craniofacial malformations, very low birth weight, ototoxic medication, stigmata/syndromes associated with hearing loss and hyperbilirubinaemia at the level of exchange tranfusion were identified to be independent significant risk factors for hearing impairment, while poor Apgar scores ...